A significant proportion of people who experienced failure of HIV treatment have resistance to tenofovir, one of the key drugs used in HIV treatment. Tenofovir is a component of the tablets Viread, Truvada, Atripla, Eviplera and Stribild.
This story has been widely reported in the mainstream media, but not always accurately. Media reports may have given the impression that, in some regions, half of all people with HIV have resistance. In fact, the study only looked at people who had taken t